论文部分内容阅读
目的:对双歧杆菌乳杆菌三联活菌片与消旋卡多曲颗粒联合在小儿腹泻疾病治疗中的临床运用效果进行探讨。方法:按随机单盲法,将2013年2月至2014年2月所收治的82例小儿腹泻患者均分为联合组与对照组,对照组予以消旋卡多曲颗粒,在此基础之上,对联合组患者予以双歧三联活菌片,且比较两组患者的治疗效果。结果:联合组患者治疗的有效率(95.1%)高于对照组(80.5%),差异明显,有统计学意义(P<0.05);联合组患者在大便性状、大便次数、发热时间以及住院时间等方面均优于对照组,差异有统计学意义(P<0.05)。结论:对小儿腹泻患者采取双歧杆菌乳杆菌三联活菌片与消旋卡多曲颗粒联合治疗,可有效改善患儿的临床症状,且疗效确切,值得大力推行、应用。
OBJECTIVE: To investigate the clinical effect of combination of Lactobacillus bifidum triple active viable tablet and racecadotril in the treatment of children with diarrhea. Methods: According to a randomized single-blind method, 82 cases of infantile diarrhea admitted from February 2013 to February 2014 were divided into the combined group and the control group. The control group was given racecadotril granules. On this basis , The combined group of patients with bifid triple live viable tablets, and compared the treatment effect of two groups of patients. Results: The effective rate (95.1%) in the combined group was significantly higher than that in the control group (80.5%), with significant difference (P <0.05). In the combined group, there was no significant difference in stool traits, stool frequency, fever time and hospital stay And other aspects are better than the control group, the difference was statistically significant (P <0.05). Conclusion: The combination of Lactobacillus bifidobacterium trifoliatum and racecadotril in children with diarrhea can effectively improve the clinical symptoms of children, and the curative effect is exact. It is worth to be vigorously promoted and applied.